Cetuximab: Uses, Interactions, Mechanism of Action | DrugBank Online
Frontiers | Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors
Structure of cetuximab showing glycosylation sites. Cetuximab is a... | Download Scientific Diagram
Cancers | Free Full-Text | Cetuximab-Mediated Protection from Hypoxia- Induced Cell Death: Implications for Therapy Sequence in Colorectal Cancer
Application of nano-surface and molecular-orientation limited proteolysis to LC–MS bioanalysis of cetuximab | Bioanalysis
WO2014125382A2 - Cetuximab with modified glycosylation and uses thereof - Google Patents
Amino acid sequence comparisons of the CDR regions for mAbs S25-26,... | Download Table
Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer - Hsu - 2019 - Cancer Medicine - Wiley Online Library
Cancers | Free Full-Text | Cetuximab-Mediated Protection from Hypoxia- Induced Cell Death: Implications for Therapy Sequence in Colorectal Cancer
A: Amino Acid Sequence of Cetuximab, heavy chain chain (Source:... | Download Scientific Diagram
In silico design, construction and cloning of Trastuzumab humanized monoclonal antibody: A possible biosimilar for Herceptin Akbarzadeh-Sharbaf S, Yakhchali B, Minuchehr Z, Shokrgozar MA, Zeinali S - Adv Biomed Res
RCSB PDB - 1YY8: Crystal structure of the Fab fragment from the monoclonal antibody cetuximab/Erbitux/IMC-C225
SMPDB
Part:BBa K1694004 - parts.igem.org
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose | NEJM
A: Amino Acid Sequence of Cetuximab, heavy chain chain (Source:... | Download Scientific Diagram
Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistance | Nature Communications
Enhancing bacterial production of a recombinant cetuximab-Fab by partial humanization and its utility for drug conjugation - ScienceDirect
Production of a germline-humanized cetuximab scFv and evaluation of its activity in recognizing EGFR- overexpressing cancer cell
From combinatorial peptide selection to drug prototype (II): Targeting the epidermal growth factor receptor pathway | PNAS
Frontiers | The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies
Structure–function relationships of the variable domains of monoclonal antibodies approved for cancer treatment
Long noncoding RNA and mRNA profiling in cetuximab‐resistant colorectal cancer cells by RNA sequencing analysis - Jing - 2019 - Cancer Medicine - Wiley Online Library
